Arbutus Biopharma Corporation
NASDAQ:ABUSBiotechnology
Healthcare
$4.07 +1.13%
+$0.05 today
- Market cap
- $623.90M
- Beta
- 0.63
- P/E (TTM)
- 5.4
- EPS (TTM)
- $0.83
52W Low $3.04High $5.10
Volume 2.44M
Average 1.76M
Price history
Arbutus Biopharma Corporation SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-3.10%
Period high
$5.22
Period low
$3.66
Latest
$4.07
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| 8-K | Nov 10, 2026 | Nov 10, 2026 | |
| 10-Q | Nov 10, 2026 | Nov 10, 2026 | |
| SC 13G/A | Oct 27, 2026 | Oct 27, 2026 | |
| 8-K | Oct 22, 2026 | Oct 22, 2026 | |
| SC 13G/A | Oct 7, 2026 | Oct 7, 2026 | |
| 4 | Oct 7, 2026 | Oct 7, 2026 | |
| 4 | Oct 7, 2026 | Oct 7, 2026 | |
| 4 | Oct 7, 2026 | Oct 7, 2026 | |
| 4 | Oct 7, 2026 | Oct 7, 2026 | |
| SC 13D/A | Oct 5, 2026 | Oct 5, 2026 | |
| 4 | Oct 5, 2026 | Oct 5, 2026 | |
| SC TO-I/A | Oct 1, 2026 | Oct 1, 2026 | |
| SC TO-I/A | Sep 30, 2026 | Sep 30, 2026 | |
| 4 | Sep 23, 2026 | Sep 23, 2026 |
Competitors
Who does Arbutus Biopharma Corporation compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about ABUS's filings, answered from its disclosures.
What is the latest ABUS filing?
The latest filing shown is 8-K dated Nov 12, 2026.
How many recent filings does ABUS have?
Intrinsic Alpha currently shows 20 recent filings for ABUS.
Continue the stock analysis
Jump to another research area for this company.